Boyers D, van der Pol M, Watson V, Lamont T, Goulao B, Ramsay C, Duncan A, Macpherson L, Clarkson J. The value of preventative dental care: a discrete-choice experiment. J Dent Res. 2021 Jul;100(7):723-30. doi: 10.1177/0022034521989943
Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.
Gray-Little B, Williams VSL, Hancock TD. An item response theory analysis of the Rosenberg self-esteem scale. Pers Soc Psychol Bull. 1997;23(5):443-51. doi: 10.1177/0146167297235001
Rothman KJ, Velez H, Glass RL, Mejia R, Espinal F. Dental caries and soil contents of trace metals in two Colombian villages. J Dent Res. 1972 Nov 1;51(6):1686.